Request Call Back
Endoscopic Submucosal Dissection (ESD): A Minimally Invasive Solution for Early GI Cancers
What is Endoscopic Submucosal Dissection (ESD)?
Endoscopic Submucosal Dissection (ESD) is an advanced endoscopic technique used for the en bloc removal (in one piece) of early-stage gastrointestinal cancers and high-grade dysplastic lesions. Unlike conventional methods such as Endoscopic Mucosal Resection (EMR), ESD allows for the complete excision of larger, deeper, or more complex lesions, especially those located in the stomach, esophagus, colon, rectum, and duodenum.
The ESD procedure involves:
· Injection of a special fluid beneath the lesion to elevate the submucosal layer.
· Careful dissection of the lesion using a specialized electrosurgical knife.
· Removal of the lesion intact, which is critical for both curative treatment and precise pathological assessment.
While technically demanding and time-consuming, ESD offers the significant benefit of achieving curative outcomes without the need for open surgery, particularly when performed in specialized centers with skilled endoscopists.
In Which Lesions Is ESD Used?
ESD is primarily indicated for early gastrointestinal cancers or precancerous lesions that are:
· Too large for standard EMR
· Poorly demarcated or flat
· Likely to have submucosal invasion
Common Indications for ESD:
1. Gastric Lesions (Stomach)
ESD is the preferred treatment for early-stage gastric cancers, especially those:
· Larger than 2 cm
· With ulceration or irregular borders
· Located in difficult anatomical areas
It has become the standard of care in Japan and South Korea, where early gastric cancer screening programs are widespread. ESD allows complete tumor removal while preserving stomach function.
2. Esophageal Lesions
ESD is used to treat:
· Squamous cell carcinoma of the esophagus
· Early Barrett’s-associated adenocarcinoma
These cancers often present as flat or poorly defined lesions. ESD ensures deep and complete removal, which reduces recurrence and may eliminate the need for esophagectomy.
3. Colorectal Lesions
ESD is beneficial for:
· Large colorectal polyps
· Superficial tumors with suspected submucosal invasion
· Lesions with non-lifting signs or recurrence after EMR
Although more technically challenging in the colon due to its thin wall and folds, ESD helps avoid colectomy in appropriately selected cases.
4. Duodenal Lesions
The use of ESD in the duodenum is limited due to higher risk of complications, particularly perforation. However, in selected cases with large, flat, or dysplastic lesions, ESD can be considered by highly experienced endoscopists.
Advantages of ESD
Compared to conventional endoscopic techniques, ESD offers several clinical benefits:
· En bloc resection allows accurate margin assessment and staging.
· Higher curative resection rates in early cancers.
· Avoidance of major surgery, reducing recovery time and complications.
· Preservation of organ integrity and function.
Risks and Considerations
Although ESD is safe in skilled hands, it carries some procedural risks:
· Perforation (1–10% depending on location)
· Bleeding, which may require endoscopic or surgical intervention
· Post-procedural pain or delayed healing
To minimize risks, ESD should be performed in centers with expertise in therapeutic endoscopy, using high-definition imaging, submucosal injection agents, and advanced dissection tools.
What to Expect During and After ESD
Before the Procedure:
· Patients undergo detailed imaging and endoscopic evaluation to assess lesion size, depth, and suitability for ESD.
· Fasting is required the night before the procedure.
· Blood thinners may be paused based on medical advice.
During the Procedure:
· The patient is typically sedated or under general anesthesia.
· A flexible endoscope with a dissection tool is inserted.
· The submucosal layer is carefully separated, and the lesion is removed.
After the Procedure:
· Most patients are monitored for 24 hours for signs of bleeding or perforation.
· Oral intake is resumed gradually.
· Pathology results guide follow-up care and determine if additional treatment (such as surgery or chemotherapy) is needed.
Conclusion
Endoscopic Submucosal Dissection (ESD) is a powerful and precise tool in the treatment of early-stage gastrointestinal cancers and high-grade dysplastic lesions. By enabling complete lesion removal without surgery, ESD reduces recovery time, preserves organ function, and improves long-term outcomes.
While it requires specialized training and equipment, ESD has proven to be highly effective and safe in expert hands. For patients with eligible lesions, this technique represents a modern, curative, and minimally invasive approach to gastrointestinal oncology.
References:
· Japanese Gastroenterological Endoscopy Society. Guidelines for ESD.
· American Society for Gastrointestinal Endoscopy (ASGE). Clinical guidelines on therapeutic endoscopy.
· National Cancer Institute (NCI): Early GI cancer treatment options.
